Globus Medical (GMED) Tops Q4 EPS by 10c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts GMED Hot Sheet
Join SI Premium – FREE
Globus Medical (NYSE: GMED) reported Q4 EPS of $0.84, $0.10 better than the analyst estimate of $0.74. Revenue for the quarter came in at $657.29 million versus the consensus estimate of $635.43 million.
GUIDANCE:
Globus Medical sees FY2025 EPS of $3.10-$3.40, versus the consensus of $3.43. Globus Medical sees FY2025 revenue of $2.8-2.9 billion, versus the consensus of $2.672 billion.
For earnings history and earnings-related data on Globus Medical (GMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ADTRAN, Inc. (ADTN) Tops Q3 EPS by 5c; offers guidance
- Janus Living, Inc. (JAN) Reports Q3 Loss of $0.02 ; Offers Guidance
- Ryman Hospitality Properties (RHP) Tops Q3 EPS by 15c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
